Skip to Content
About Abbott
Contact
United States | eng
Country Language
CARDIOVASCULAR
United States | eng
Country Language

HeartMate 3 LVAD

With Full Maglev Flow Technology

HeartMate 3 LVAD
Patient Education

HeartMate 3 LVAD Patient Education

Patients with advanced heart failure may not fully grasp that heart failure is a serious, progressive disease. They may not realize how sick they truly are until it’s too late.

You can help your patients understand if HeartMate 3™ LVAD therapy might be a treatment option before their heart failure progresses, giving them more time to decide and plan for their heart failure treatment.

Download LVAD Patient Brochure

Here are a few points you might want to share with your patients:

  • LVAD therapy is an option for patients with NYHA Class IIIB-IV heart failure
  • HeartMate 3 LVAD is a small implantable pump that is designed to help their heart pump blood
  • There have been significant clinical advancements in LVAD therapy, with HeartMate 3 LVAD survival rate now comparable to heart transplant at 2 years1,2*
  • HeartMate 3 LVAD has an excellent safety profile, with reduced stroke and pump thrombosis adverse events rates3

View MOMENTUM 3 Trial Data

Resources to Support LVAD Patient Education & Discussion

LVAD Pre-Implant Patient Education Videos

LVAD Pre-Implant Patient
Education Videos

LVAD Post-Implant Patient Education Videos

LVAD Post-Implant Patient
Education Videos

Live a More Active Life with an LVAD

Review fast facts and helpful information about living life with a HeartMate 3 LVAD..

Download
HeartMate 3 LVAD Patient brochure

HeartMate 3 Left Ventricular Assist Device (LVAD) Patient Guide

This guide helps patients and caregivers become familiar with the HeartMate 3 LVAD upon hospital discharge.

Download
Cover of HeartMate 3 Patient Guide with an older adult man and woman.
Find a HeartMate 3 LVAD Center

Find a HeartMate 3 LVAD Center

HeartMate 3 Patient Information

HeartMate 3 Patient Information

Customer Service

Customer Service

*Based on published data from separate datasets, which may involve different patient populations and other variables. Not a head-to-head comparison. Data presented for informational purposes only.

References

  1. Teuteberg JJ, Cleveland JC, Cowger J, Higgins RS, et al. The Society of Thoracic Surgeons Intermacs 2019 Annual Report: the changing landscape of devices and indications. Ann Thorac Surg. 2020;109:649-660.
  2. Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplant Report-2018: Focus Theme: Multiorgan Transplantation. J Heart Lung Transplant 2018:37:1155-1168.
  3. Mehra MR, Uriel N, Naka Y, et al. A Fully Magnetically Levitated Ventricular Assist Device-Final Report. N Engl J Med. 2019;380:1618-1627.

MAT-2012376 v3.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
abbott logo

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-1900882 v12.0